TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CING

Cingulate Inc

Healthcare · Biotechnology

4.90$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Cingulate Inc (CING) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CING
Line item 2019 2020 2021 2022 2023 2024 2025
-9.5 -6.8 -10 -16 -15 -18 -17
0.2 0.7 0.7 0.4 0.6 0.7 0.5
– 0.0 13 0.8 0.8 1.0 1.5
0.0 13 13 0.8 – – –
1.9 -0.3 -3.2 0.6 7.1 -4.6 0.8
1.0 0.4 0.8 0.2 0.2 0.2 0.2
2.7 -0.4 -0.8 -0.2 -0.2 -0.2 -0.2
0.5 0.5 -0.9 5.0 3.0 4.9 6.0
6.1 8.0 27 4.9 10.0 31 16
-0.6 0.8 15 -11 -5.3 12 -1.3
-11 -7.2 -11 -16 -15 -19 -17

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?